On Sunday, Senate Republicans struck down a proposal to cap out-of-pocket insulin costs for non-Medicare patients. The price of the century-old medication has tripled over two decades, forcing patients with diabetes to spend thousands of dollars on the life-saving drug. More than 7 million Americans rely on insulin to manage their diabetes. Sen.